M icroalbuminuria, defined as an urinary albumin excretion (UAE) ranging between 30 and 300 mg/24 h, has been demonstrated as an independent predictor of increased cardiovascular risk in diabetic patients, 1,2 as well as in essential hypertensives. 3, 4 The pathophysiologic mechanisms leading to increased UAE in hypertension are still not completely understood. It has been proposed that insulin resistance and hyperinsulinemia, frequently found in hypertensives, 5 could be related to the development of microalbuminuria. Clinical studies evaluating this relationship in hypertensives, in diabetics, and in the general population, have yielded conflicting results; microalbuminuria and insulin resistance are independent of each other, according some investigators, 6 -9 closely related, according other researchers. 10 -17 The discrepancies among the results could probably be ascribed to differences with regard to not only the methods used for the insulin sensitivity evaluation, but also the criteria of patients selection; above all, the frequent enrollment of hypertensive subjects already on drug treatment could have influenced the results, as antihypertensive therapy is known to modify both UAE and insulin sensitivity. 18, 19 Looking for a possible influence of genetic factors, some but not all investigators, have found an increased prevalence of microalbuminuria among offspring of hypertensives. 4,20 -23 On the other hand, genetic predisposition to hypertension has been recently found to play an important role in linking insulin resistance and hypertension. In fact, a reduced insulin sensitivity has been demonstrated in lean and obese normotensives and hypertensives with hypertensive parents compared with offspring of normotensives.
24 -28 Therefore, we have considered it of interest to evaluate whether microalbuminuria and hyperinsulinemia are related in never-treated essential hypertensives, taking also into account the possible influence of family history of hypertension.
METHODS
Patients We studied hypertensive patients (H), never treated with antihypertensive drugs, without a family history of diabetes mellitus, and with fasting plasma glucose Ͻ100 mg/dL, normal urinalysis and creatinine clearance Ͼ80 mL/min/1.73 m 2 . Arterial blood pressure (BP) was evaluated on the basis of at least three measurements by sphygmomanometer, taken on different days. We selected subjects with BP Ͼ160 and/or 95 mm Hg. Subsequently, each patient underwent a 24-h noninvasive ambulatory BP monitoring and patients with mean 24-h BP Ͼ140 and/or 90 mm Hg were enrolled in the study. A basic criterion of selection was the opportunity to assess family history of hypertension on the basis of the parents' history and BP. Negative family history (FϪ) was established when both parents were living and had BP Ͻ140/90 mm Hg; positive family history (Fϩ) was established when at least one parent was living and had BP Ͼ160/95 mm Hg or one or both parents had a history of chronic antihypertensive treatment. Parental BP was measured by sphygmomanometer three times on different days, by one of the investigators.
According to these criteria we selected 92 H (57 men, 35 women; mean age, 42 Ϯ 7 years; mean body mass index, 25.2 Ϯ 3.9 kg/m 2 ). The study protocol was approved by the Ethical Committee of the Department of Clinical and Biological Sciences and all the subjects gave their informed consent.
Protocol All patients, after a clinical work-up to rule out secondary hypertension, underwent 24-h ambulatory BP monitoring, urinary albumin excretion measurements, and oral glucose tolerance test.
Microalbuminuria Each patient collected 24-h urine twice, 1 week apart, for determination of UAE; the patients have been instructed to maintain their usual diet and to avoid sustained physical activity during the 2 days of urine collection. Urinary albumin concentration was measured by an immunonephelometric method (microAlbumin Beckman, Galway, Ireland); the intraassay and interassay variabilities of the method were Ͻ5% and Ͻ7%, respectively. For each patient the UAE was considered the mean of values obtained from the two separate 24-h urine collections. If the difference between values obtained from the two samples was Ͼ25% of the higher value, a third sample was requested. Microalbuminuria was defined as UAE between 30 and 300 mg/24 h, for the average of the two urine collections.
Oral Glucose Tolerance Test Two or 3 days after the 24-h ambulatory BP monitoring, each subject underwent, at 8:00 am, after an overnight fast, a 75-g oral glucose tolerance test (OGTT). Plasma glucose (G) and serum insulin (I) were determined before and 30, 60, 90, and 120 min after the glucose load. The values obtained during OGTT have been expressed as area under the curve (AUC), measured using the trapezoidal rule. Using insulin and glucose values at the glucose peak (p) we also evaluated an index of peripheral insulin activity (Ia) based on the formula: Ia ϭ 10 4 / I p G p . 29 Serum insulin was measured by an antibody method with a solid-phase 125 I radioimmunoassay (Coat-A-Count Insulin, Diagnostic Products Corp., Los Angeles, CA). The method has a sensitivity of 1.1 UI/mL and a coefficient of variation of 7.1% at insulin values of 1 to 40 UI/mL.
Twenty-four-Hour Ambulatory BP Monitoring
Noninvasive ambulatory BP monitoring was performed with a portable automated Takeda TM 2421 (ARD Co. Ltd., Tokyo, Japan) and a simultaneous 24-h heart rate monitoring was obtained. The unit was set to take readings every 15 min throughout the 24 h. The following parameters have been evaluated: mean 24-h, daytime (from 7:00 am to 10:00 pm), and nighttime (from 10:00 pm to 7:00 am) systolic and diastolic BP and heart rate, percent nocturnal decrease of systolic and diastolic BP.
Statistical Analysis
The statistical evaluation of the results was carried out by means of unpaired Student's t test and 2 test. Pearson's linear correlation coefficients and multiple regression analysis were used to evaluate linear relationships between variables. Data are expressed as mean Ϯ standard deviation; a P value Ͻ.05 was considered statistically significant.
RESULTS
Grouping the 92 patients on the basis of normal or increased UAE, we obtained two groups: 31 hypertensives with microalbuminuria and 61 hypertensives with normal (Ͻ30 mg/24 h) UAE. The two groups were not significantly different with regard to age, gender, body mass index, mean 24-h, daytime and nighttime heart rate ( Table 1) . Mean 24-h, daytime and nighttime systolic and diastolic BP were higher in the group with microalbuminuria, whereas mean values of percent nocturnal decrease of systolic and diastolic BP were similar between the two groups (Table 1) , as was the prevalence of nondippers (nocturnal BP decrease Ͻ10% of daytime BP): 8 patients with microalbuminuria (25.8%) and 14 with normal UAE (23%) (P ϭ NS). Considering the 92 patients as a whole, from multiple regression analysis (multiple r ϭ 0.51, P ϭ .003) the major independent predictor for UAE among the BP parameters was daytime diastolic BP (␤ ϭ 0.48, P ϭ .002), whereas the extent of nocturnal decrease of systolic and diastolic BP did not enter into the equation.
The prevalence of a positive family history of hypertension was similar between the two groups: 67% of hypertensives with normal UAE and 58% of hypertensives with microalbuminuria had one or both parents hypertensive (P ϭ NS) ( Table 1) . Glucose values, both fasting and during OGTT, were within the normal limits in all subjects and similar between the two groups; fasting insulin, insulin AUC during OGTT, and the index of peripheral insulin activity were also not significantly different between subjects with and without microalbuminuria ( Table 2) .
Grouping the 92 patients on the basis of family history of hypertension, 59 subjects had one or both hypertensive parents (Fϩ) and 33 had both normotensive parents (FϪ). UAE, 24-h, daytime and nighttime systolic and diastolic BP, and the extent of nocturnal BP decrease were not statistically different between the Fϩ and FϪ (Table 3) . With regard to metabolic parameters, plasma glucose values, both fasting and during OGTT were similar between the two groups, whereas fasting and stimulated insulin values were 
TABLE 2. MEAN VALUES (؎ SD) OF FASTING GLUCOSE (G, mg/dL), FASTING INSULIN (I, UI/ mL), GLUCOSE AREA DURING OGTT (G-AUC), INSULIN AREA DURING OGTT (I-AUC), AND INDEX OF PERIPHERAL INSULIN ACTIVITY (Ia) IN HYPERTENSIVES WITH (MA؉) AND WITHOUT
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significantly higher and index of peripheral insulin activity lower in hypertensives with a family history of hypertension compared to hypertensives with normotensive parents (Table 3) . Considering the 92 patients as a whole, as well as grouping them on the basis of microalbuminuria or family history of hypertension, UAE did not correlate with glucose and insulin parameters and these latter did not correlate with 24-h, daytime, nighttime BP, and the extent of nocturnal BP decrease.
DISCUSSION
The aim of the study was to evaluate whether microalbuminuria and hyperinsulinemia are related to each other in nondiabetic essential hypertensives and to verify the possible influence of genetic predisposition to hypertension.
Designing the study we selected subjects with sustained hypertension, evaluating BP not only by means of repeated clinic measurements, but also with 24-h ambulatory BP monitoring and using an high cutoff BP value for enrollment: mean 24 h BP Ͼ140 and/or 90 mm Hg. Moreover, we selected only subjects never treated with antihypertensive drugs, as treatment can induce changes of both microalbuminuria and insulin sensitivity. 18, 19 The BP of the parents was directly and repeatedly assessed to avoid the recruitment of subjects with an incorrectly defined family history of hypertension.
Microalbuminuria was found in 33.7% (31 patients) of the 92 hypertensives examined, a prevalence that is in keeping with the data from the literature, reporting that microalbuminuria is present in 20% to 40% of sustained hypertensives, 10,11,30 -32 whereas some researchers found a prevalence Ͻ10%, but evaluating patients with BP values lower than in our study. 21, 22 Comparing subjects with and without microalbuminuria, as previously demonstrated, 10, 21, 30, 32 we found that increased UAE was associated with higher BP values and the major independent determinant of UAE among BP parameters was daytime diastolic BP. The extent of nocturnal BP decrease and the prevalence of nondippers were not significantly different between the two groups, whereas some investigators 33, 34 have reported that patients with microalbuminuria are more likely to be nondipper than dipper and that the day/night BP ratio is an independent determinant of UAE. In evaluating these discrepancies it must be taken into account that the characterization of patients as dipper or nondipper on the basis of one 24-h BP monitoring has a poor test/retest reliability and therefore is of questionable clinical value. 35 With regard to the possible association of microalbuminuria with insulin resistance, we did not find any relationship between increased UAE and reduced insulin sensitivity. This latter was assessed by means of glucose and insulin response to an oral glucose load. The method does not allow a direct measurement of insulin sensitivity, but insulin AUC during OGTT and the index of peripheral insulin activity derived from glucose and insulin values at glucose peak have been demonstrated to correlate well with insulin sensitivity measured by the euglicemic clamp. 29, 36 Glucose and insulin values, fasting and during test, were similar between subjects with and without microalbuminuria, as was the index of peripheral insulin activity. Moreover, UAE did not correlate with metabolic parameters, considering the 92 patients as a whole, as well as grouping them on the basis of presence or absence of microalbuminuria.
As both insulin sensitivity and microalbuminuria have been related by some studies to genetic predisposition to hypertension, we evaluated the possible influence of positive family history of hypertension. First, we did not find any significant association between presence of microalbuminuria and genetic predisposition to hypertension. In fact, the prevalence of a positive family history of hypertension was similar between hypertensives with and without microalbuminuria and, grouping the 92 patients on the basis of family history of hypertension, UAE was similar between offspring of hypertensives and offspring of normotensives. This finding is in agreement with some previous studies, 4, 21, 23 whereas other investigators 13, 20 reported a higher prevalence of microalbuminuria or a higher UAE in subjects with a positive family history of hypertension than in offspring of normotensives. It must be emphasized that in all these studies family history of hypertension was established only on the basis of the parents' history, without a direct assessment of the parents' BP, as done in our study. The results obtained grouping the patients on the basis of family history of hypertension also supported the lack of association between microalbuminuria and reduced insulin sensitivity. Despite similar glucose values, fasting and during the test, offspring of hypertensives had higher insulin values and lower index of peripheral insulin activity compared with offspring of normotensives, whereas UAE was similar between the two groups. These results, besides confirming 24 -28 that genetic factors play a relevant role in linking insulin resistance and hypertension, show that microalbuminuria and reduced insulin sensitivity are not related to each other. The finding, in keeping with some previous studies, 6 -9 is not consistent with others 10 -17 that found a close relationship, possibly causal, between insulin resistance and increased UAE. In evaluating the different results it has to be emphasized that in some studies the association disappears after taking into account body weight and glucose values. 11, 12 Moreover, the studies are different with regard to the insulin sensitivity assessment and, above all, to the enrollment of patients previously treated with antihypertensive drugs and to the number of microalbuminuric patients examined, very low in some studies. 10, 15 In conclusion, from our results, microalbuminuria is associated with higher BP values, but is not related to reduced insulin sensitivity and is not influenced by family history of hypertension. Therefore, in nevertreated nondiabetic sustained hypertensives, development of microalbuminuria and impairment of insulin sensitivity represent, in our opinion, two components of the hypertensive syndrome, largely independent of each other.
